1
Back
Nature Reviews Clinical Oncology cover

Nature Reviews Clinical Oncology

IF82.2
Papers2343
Citations33364
Journal Papers 2385
Publication Date
delete
Precision oncology needs precision trial design: lessons from FGFR2-rearranged cholangiocarcinoma
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-08-12
delete0
PREAI
deleteFen Saj; Lipika Goyal
deleteShare
deleteSave
How positive was PROTEUS? Reconsidering success when most patients never reach no evidence of disease
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-08-11
delete0
PREAI
deleteDaniel E. Spratt
deleteShare
deleteSave
The proteome comes of age, but precision oncology needs functional maps
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-08-10
delete0
PREAI
deleteEmanuel Petricoin; Thomas Conrads; Lance Liotta
deleteShare
deleteSave
AI-based augmentation of oncology clinical trials
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-08-07
delete0
PREAI
deleteAndrea Villa; Ashley L. Eadie; David Synnott; Rebecca Romanò; Max Piffoux; Evelyn Yi Ting Wong; Naomi Scheinerman; Daniel S. W. Tan; Filippo Guglielmo Maria de Braud; Miriam Koopman; Jarushka Naidoo; Madhusmita Behera; Selen Bozkurt; Susan Halabi; Rodrigo Dienstmann; Loic Verlingue; Arsela Prelaj; Ravi B. Parikh
deleteShare
deleteSave
HCT–ASCT confirmed as standard-of-care consolidation therapy for PCNSL
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-08-07
delete0
PREAI
deleteDavid Killock
deleteShare
deleteSave
Benefit from perioperative enfortumab vedotin–pembrolizumab in cisplatin-eligible MIBC
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-08-04
delete0
PREAI
deleteDiana Romero
deleteShare
deleteSave
More options, more questions in the management of early relapsed and/or refractory multiple myeloma
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-07-31
delete0
PREAI
deleteCarlyn Rose Tan; Sham Mailankody
deleteShare
deleteSave
Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-07-30
delete0
PREAI
deleteSolange Peters; Petros Grivas; Christophe Massard; Sara M. Tolaney; Michel Obeid
deleteShare
deleteSave
De-escalation trials in multiple myeloma: past, present and future
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-07-29
delete0
PREAI
deleteHira Mian; Luciano J. Costa; Mohamad Mohty; Alfred Garfall; S. Vincent Rajkumar
deleteShare
deleteSave
Electronic cigarettes, smoking and lung cancer risk: some evidence about the continuum of harm
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-07-28
delete0
PREAI
deletePeter G. Shields
deleteShare
deleteSave
Towards liquid biopsy-based analysis of antitumour immunity
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-07-24
delete0
PREAI
deleteKlaus Pantel; Doryan Masmoudi; Catherine Alix-Panabières
deleteShare
deleteSave
Does OptiTROP-Lung05 open a new frontier for first-line ADC–ICI combinations in NSCLC?
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-07-20
delete0
PREAI
deleteMyung-Ju Ahn
deleteShare
deleteSave
Second-line 177Lu-edotreotide shows promise in GEP NETs
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-07-16
delete0
PREAI
deleteDiana Romero
deleteShare
deleteSave
Crossover does not confound, it informs: 177lutetium-PSMA-617 as an example
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-07-16
delete0
PREAI
deleteMartin W. Schoen; Tito Fojo; Johann de Bono
deleteShare
deleteSave
Ciltacabtagene autoleucel heralds the arrival of fixed-duration therapies in myeloma
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-07-14
delete0
PREAI
deleteGhulam Rehman Mohyuddin; Edward R. Scheffer Cliff; Rajshekhar Chakraborty
deleteShare
deleteSave
The future of ciltacabtagene autoleucel in multiple myeloma has just begun
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-07-14
delete0
PREAI
deleteMaximilian Merz; Nico Gagelmann
deleteShare
deleteSave
CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-07-09
delete0
PREAI
deleteSamuel Grigg; Carolyn Shembrey; Mohamed Fareh; Piers Blombery; Jacob E. Corn; John F. Seymour; Joshua M. L. Casan
deleteShare
deleteSave
Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-06-30
delete0
PREAI
deleteYago Garitaonaindia; Heather A. Wakelee; Martin Reck; Patrick M. Forde; Tina Cascone; Jonathan D. Spicer; Mariano Provencio
deleteShare
deleteSave
Patient value over patent value: the mandate for open-source oncology
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-06-26
delete0
PREAI
deleteBibek Aryal; Dario Trapani
deleteShare
deleteSave
Cancer burden and control in China: landscape, trends and challenges
deleteNature Reviews Clinical Oncology
IF82.2
delete2026-06-19
delete0
PREAI
deleteChangfa Xia; He Li; Chen Wu; Wanqing Chen
deleteShare
deleteSave